全文获取类型
收费全文 | 2350141篇 |
免费 | 171228篇 |
国内免费 | 3331篇 |
专业分类
耳鼻咽喉 | 32049篇 |
儿科学 | 75891篇 |
妇产科学 | 62685篇 |
基础医学 | 348165篇 |
口腔科学 | 63633篇 |
临床医学 | 211343篇 |
内科学 | 457268篇 |
皮肤病学 | 51727篇 |
神经病学 | 185270篇 |
特种医学 | 88006篇 |
外国民族医学 | 489篇 |
外科学 | 353855篇 |
综合类 | 47509篇 |
现状与发展 | 12篇 |
一般理论 | 848篇 |
预防医学 | 182729篇 |
眼科学 | 54325篇 |
药学 | 175102篇 |
11篇 | |
中国医学 | 4575篇 |
肿瘤学 | 129208篇 |
出版年
2021年 | 18980篇 |
2019年 | 19537篇 |
2018年 | 27057篇 |
2017年 | 20358篇 |
2016年 | 22745篇 |
2015年 | 25638篇 |
2014年 | 36094篇 |
2013年 | 53952篇 |
2012年 | 74674篇 |
2011年 | 79405篇 |
2010年 | 47055篇 |
2009年 | 44564篇 |
2008年 | 74607篇 |
2007年 | 79476篇 |
2006年 | 80293篇 |
2005年 | 77777篇 |
2004年 | 74365篇 |
2003年 | 71689篇 |
2002年 | 69362篇 |
2001年 | 108737篇 |
2000年 | 111450篇 |
1999年 | 93494篇 |
1998年 | 26990篇 |
1997年 | 23658篇 |
1996年 | 24054篇 |
1995年 | 22715篇 |
1994年 | 20893篇 |
1993年 | 19712篇 |
1992年 | 72000篇 |
1991年 | 70069篇 |
1990年 | 68391篇 |
1989年 | 65663篇 |
1988年 | 60302篇 |
1987年 | 59125篇 |
1986年 | 55217篇 |
1985年 | 53004篇 |
1984年 | 39311篇 |
1983年 | 33396篇 |
1982年 | 19858篇 |
1979年 | 35866篇 |
1978年 | 25651篇 |
1977年 | 21230篇 |
1976年 | 20332篇 |
1975年 | 21816篇 |
1974年 | 26148篇 |
1973年 | 24802篇 |
1972年 | 23200篇 |
1971年 | 22037篇 |
1970年 | 20247篇 |
1969年 | 19315篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
901.
Adult body height, self perceived health and mortality in the Swedish population. 总被引:10,自引:8,他引:2 下载免费PDF全文
STUDY OBJECTIVE: The purpose of the study was to examine adult body height as an indicator of general health. DESIGN: The study was a survey of a randomly selected sample of the adult Swedish population obtained by the Swedish National Central Bureau of Statistics. PARTICIPANTS: The sample studied was identified in 1980-81 and comprised 14,757 persons aged 16-74. Of these, 12,695 (86%) consented to interview. MEASUREMENTS AND MAIN RESULTS: Information was obtained on adult height, socioeconomic status in childhood and adult life, self perceived health, self reported longstanding illness, and mortality during a six year follow up. The numbers of people in three height groups who considered their general health as bad, who reported any longstanding illness or who died during the follow up were compared with the expected numbers in the same groups. The number of persons with reduced health and the number of deaths was larger than expected in the shortest height group. The excess risk of dying in the shortest group (about 20% higher compared to the tallest group) was reduced but not eliminated when present and childhood socioeconomic group was taken into account. Coronary heart disease mortality in particular was linked to height. The shortest group of men and women reported the largest proportion with bad general health and longstanding illness. For the latter the differences between height groups disappeared after controlling for present socioeconomic status. CONCLUSIONS: There is a detectable excess risk of morbidity and mortality from being short. Assuming that the childhood environment is an important determinant of adult stature it is also important for adult health. 相似文献
902.
J A Scatina D R Hicks M Kraml M N Cayen 《Xenobiotica; the fate of foreign compounds in biological systems》1989,19(9):991-1002
1. The disposition of AY-30,068 (I), a new tetrahydrocarbazole analgesic drug, was studied in mice, rats, dogs, rhesus monkeys, and man. 2. Oral doses of the 14C-labelled drug in aqueous solution were well absorbed in rodents, but absorption of oral doses of the crystalline drug in dogs was poor. Due to the virtual absence of serum metabolites in rats and dogs, the bioavailability of I was nearly identical to the extent of absorption. Although a small first-pass effect was observed in mice, unchanged I represented a major portion of serum radioactivity. 3. A linear increase in the serum concentrations of I occurred at doses between 0.05 and 25 mg/kg in rats, 0.1 and 50 mg/kg in dogs, and 1-160 mg in man. In rhesus monkeys given a 0.5 mg/kg oral dose, the Cmax and AUC of I were similar to values obtained following a corresponding dose in dogs. 4. After i.v. administration of a 1.0 mg/kg dose the terminal elimination half-life (t1/2 beta) of I was 4 h in mice and 9-10 h in rats and dogs. In rodents, dogs, and several human subjects, the elimination of I was interrupted by secondary peaks. Enterohepatic circulation was confirmed in bile duct cannulated rats, where the t1/2 beta of I was decreased to 2.4 h. In rodents the serum clearance and apparent volume of distribution of I were 0.04-0.2 l/kg.h and 0.5-0.8 l/kg, respectively, and 0.6 l/kg.h and 9.8 l/kg in dogs. 5. In rodents and dogs dosed with 14C-labelled I, radioactivity was excreted almost entirely in the faeces. No unchanged I was detected in rat bile, while about 70% of the radioactivity corresponded to conjugates of parent drug. 相似文献
903.
904.
905.
906.
907.
J. Saßmannshausen N. Bornfeld A. Kluge W. Sauerwein F. Härting A. Wessing 《International ophthalmology》1989,13(4):243-251
Advanced malignant melanomas of the uvea unsuited for an eye salvaging approach require enucleation of the tumor containing eye. A series of 68 patients is reported who underwent enucleation combined with insertion of a spherical dura-encased implant after 30 Gray pre-irridiation therapy of the orbit. Postoperative results with special attention to cosmetic outcome and motility of the prosthesis suggest that the insertion of an orbital implant should be preferred to the enucleation with no implant. 相似文献
908.
Fatal and non-fatal stingray envenomation 总被引:2,自引:0,他引:2
A fatality occurred in a previously healthy 12-year-old boy after a penetrating chest injury from a stingray barb. The injury occurred under freak circumstances. Death was a result of cardiac tamponade which was secondary to venom-induced, localized myocardial necrosis and spontaneous perforation, six days after the direct penetration of the right ventricle by the barb. Three other cases of less serious stingray envenomation are described which illustrate the significant localized morbidity that may occur without immediate wound exploration and toilet after adequate anaesthesia. We also report a study of a series of 100 minor stingray envenomations which, when treated, resulted in no morbidity. It is possible that local infiltration with 1% plain lignocaine may have a direct counteraction against stingray venom that remains in the wound area. Stingray venom has insidious, but powerful, localized tissue necrosing properties in humans. 相似文献
909.
Dihydroxyacetone (DHA), a browning agent, protects photosensitive rats and humans against long ultraviolet radiation (UVA, 320-400 nm) and visible (blue) light. The photoprotective efficacy of DHA and structurally similar compounds was assessed as prevention of edema in the paws of psoralen-sensitized rats, after exposure to blacklight fluorescent lamps. Methylglyoxal produced a yellow-brown color and provided nearly the same protection as DHA, whereas monohydroxyacetone did not color the skin and afforded little or no protection. Glyceraldehyde provided a moderate amount of protection, which was enhanced by prior exposure of the agent to alkaline pH. A solution of 5-hydroxymethylfurfuraldehyde was yellow and provided minimal protection by staining the skin rather than browning it. We conclude that the ability to produce a brown color in skin is a useful criterion for screening compounds for photoprotective efficacy against UVA radiation. 相似文献
910.
VECURONIUM AND ATRACURIUM IN PATIENTS WITH END-STAGE RENAL FAILURE: A Comparative Study 总被引:2,自引:0,他引:2
LEPAGE J. Y.; MALINGE M.; COZIAN A.; PINAUD M.; BLANLOEIL Y.; SOURON R. 《British journal of anaesthesia》1987,59(8):1004-1010
Twenty patients with end-stage renal failure, undergoing kidneytransplantation, were assigned randomly to receive either vecuroniumor atracurium under evoked twitch tension control. The cumulative-dosetechnique was used to obtain 95% twitch depression (vecuronium:initial bolus 15 µg kg1, increments 6 µgkg1; atracurium: initial bolus 100 µg kg1,increments 40 µg kg1). Using ED95 values derivedfrom the log-probit dose-response curves, vecuronium was 4.6times more potent than atracurium. The durations of action ofthe initial cumulativedoses (from end of injection of the lastincrement to 25% recovery) were 11.1± 3.3 min for vecuroniumand 16.2±3.9 min for atracurium (P < 0.05). In termsof duration of action of the maintenance doses (vecuronium one-quarterof the total incremental dose; atracurium one-third) some cumulationwas observed with vecuronium (interaction time x treatment;cumulation ratio 1.46 ±0.31 v. 0.98±0.10 for atracurium,P< 0.001). After 2 h of surgery, the mean recovery times(25% to 75% twitch height) did not differ (18.5±2.8 minand 16.7±4.4 min). It is concluded that vecuronium mightbe less safe than atracurium in patients with end-stage renalfailure undergoing prolonged operations. 相似文献